Josh Wardle hopes his digital take on the cryptic crossword can be a gradual on-ramp crossing the cultural divide between Britain and the US In 2021, Josh Wardle became a household name almost ...

Posts from this topic will be added to your daily email digest and your homepage feed. is an investigations editor and feature writer covering technology and the people who make, use, and are affected ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Lexicon Pharmaceuticals shares were 21% lower, at $1.14, after the company priced its underwritten public offering of 32 million shares at $1.30 a share. All of the shares are being offered by Lexicon ...

Arkansas-based Lexicon Inc. announced Thursday (Jan. 22) it has become an employee-owned company through the establishment of an Employee Stock Ownership Plan (ESOP). The decision follows a ...

The last time I spoke about Lexicon Pharmaceuticals, Inc. (LXRX) it was with respect to a Seeking Alpha article entitled "Advisory Panel Votes In Split Fashion For Lexicon's Drug: What does That Mean ...

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of a fully integrated immune repertoire and ...

Lexicon Inc., a Little Rock-based construction management and steel fabrication company, said Thursday it has become a private, employee-owned company. Lexicon said the decision comes after a ...

(RTTNews) - Lexicon Pharmaceuticals Inc. (LXRX) announced that the U.S. FDA raised no objections to advancing Pilavapadin into Phase 3 development following a successful End-of-Phase 2 meeting for the ...

Lexicon Pharmaceuticals is positioned for a potential turnaround with three key drug programs and recent partnerships, despite a challenging history. LXRX's sotagliflozin faces uncertain FDA approval ...